Sema3A Recombinant Protein

<strong>Sema3A Recombinant Protein</strong>_x000D_ <strong>Catalog number:</strong> B2019384_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5  µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 125kD_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Sema3A Recombinant Protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Balasubramanian R, Crowley WF Jr. Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency 2007 May 23 [updated 2022 May 12]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024._x000D_ 2: Zheng Y, Jiang F, Wang C, Dong M, Wang C, Yan E, Wang Y, Zhu Z, Xiong X, Ding X, Ye J, He Y, Zhang H, Zhou J, Zhang W, Wu Y, Song X. Regulation of Semaphorin3A in the process of cutaneous wound healing Cell Death Differ. 2022 Oct;29(10):1941-1954._x000D_ 3: Sang Y, Tsuji K, Inoue-Torii A, Fukushima K, Kitamura S, Wada J. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury Int J Mol Sci. 2020 Jun 8;21(11):4099._x000D_ 4: Lu D, Shang G, He X, Bai XC, Zhang X. Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex Nat Commun. 2021 May 26;12(1):3172._x000D_ 5: Fang W, Wang Z, Li Q, Wang X, Zhang Y, Sun Y, Tang W, Ma C, Sun J, Li N, Yi F. Gpr97 Exacerbates AKI by Mediating Sema3A Signaling J Am Soc Nephrol. 2018 May;29(5):1475-1489._x000D_ 6: Pérez Y, Bonet R, Corredor M, Domingo C, Moure A, Messeguer À, Bujons J, Alfonso I. Semaphorin 3A-Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration Pharmaceuticals (Basel). 2021 Sep 7;14(9):906._x000D_ 7: Hayashi M, Kamiya Y, Itoh H, Higashi T, Miyazaki T, Funakoshi K, Yamashita N, Goshima Y, Andoh T, Yamada Y, Goto T. Intrathecally administered Sema3A protein attenuates neuropathic pain behavior in rats with chronic constriction injury of the sciatic nerve Neurosci Res. 2011 Jan;69(1):17-24._x000D_ 8: Chan-Juan H, Sen L, Li-Qianyu A, Jian Y, Rong-Di Y. MicroRNA-30b regulates the polarity of retinal ganglion cells by inhibiting semaphorin-3A Mol Vis. 2019 Nov 14;25:722-730. eCollection 2019._x000D_ 9: Xing Q, Feng J, Zhang X. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway Exp Cell Res. 2021 Jun 1;403(1):112595._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28636974">10: Palodetto B, da Silva Santos Duarte A, Rodrigues Lopes M, Adolfo Corrocher F, Roversi FM, Soares Niemann F, Priscila Vieira Ferro K, Leda Figueiredo Longhini A, Melo Campos P, Favaro P, Teresinha Olalla Saad S. SEMA3A partially reverses VEGF effects through binding to neuropilin-1 Stem Cell Res. 2017 Jul;22:70-78. </a>_x000D_ _x000D_ <strong>Products Related to Sema3A Recombinant Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>